Skip to main content
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
Full Chart
Watchlist
Compare
11.95
-0.67 (-5.31%)
May 15, 2026, 4:00 PM EDT - Market closed
Overview
Financials
Forecast
Statistics
Metrics
History
Profile
Chart
Metrics
Revenue by Type
Software Products and Services Revenue Breakdown
Drug Discovery Revenue Breakdown
Revenue by Geography
Schrödinger Revenue by Type
Quarterly
TTM
Download
Period Ending
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Software Products and Services
186.24M
199.50M
209.92M
200.94M
195.80M
180.40M
169.40M
166.42M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Software Products and Services Growth
-4.88%
10.59%
23.92%
20.74%
22.09%
13.34%
22.52%
24.17%
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Drug Discovery
68.66M
56.37M
47.12M
37.06M
34.77M
27.22M
24.02M
34.28M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Drug Discovery Growth
97.47%
107.09%
96.16%
8.10%
23.37%
-52.72%
-60.67%
-42.60%
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Software Products and Services Revenue Breakdown
Period Ending
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Software Products and Services
26.88M
27.51M
27.26M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Software Products and Services Growth
-2.04%
1.09%
0.40%
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Software Contribution
12.14M
15.99M
18.18M
16.37M
11.86M
8.02M
3.12M
1.80M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
-
-
-
Software Contribution Growth
2.39%
99.45%
481.91%
809.61%
558.89%
345.33%
73.56%
-
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
-
-
-
Drug Discovery
11.71M
12.98M
7.15M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Drug Discovery Growth
8.73%
63.40%
-16.15%
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Drug Discovery Revenue Breakdown
Period Ending
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Drug Discovery Services Customer Contracts
67.40M
54.76M
45.32M
35.12M
32.69M
25.14M
21.97M
31.88M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Drug Discovery Services Customer Contracts Growth
106.21%
117.79%
106.30%
10.16%
27.64%
-54.05%
-62.27%
-44.26%
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Drug Discovery Contribution
1.26M
1.61M
1.76M
1.89M
2.04M
2.03M
2.02M
2.37M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Drug Discovery Contribution Growth
-38.30%
-20.78%
-13.29%
-20.12%
-19.95%
-28.03%
-29.72%
-6.89%
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Revenue by Geography
Period Ending
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
United States
154.71M
152.96M
131.30M
124.59M
121.24M
114.87M
133.14M
141.65M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
United States Growth
27.61%
33.16%
-1.39%
-12.05%
-10.14%
-29.08%
-8.89%
0.83%
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
EMEA
72.25M
75.16M
91.28M
80.70M
81.54M
65.65M
33.86M
32.48M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
EMEA Growth
-11.39%
14.49%
169.56%
148.50%
176.37%
125.33%
22.28%
14.51%
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
APAC
26.78M
26.18M
32.70M
31.23M
26.38M
25.80M
25.18M
25.47M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
APAC Growth
1.54%
1.47%
29.87%
22.62%
14.69%
5.02%
-19.14%
-16.40%
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Rest of World
1.16M
1.56M
1.67M
1.40M
1.35M
1.22M
1.16M
1.03M
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Rest of World Growth
-13.53%
28.16%
44.18%
35.43%
25.94%
21.68%
-
-
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Upgrade
Source:
Business metrics provided by
TipRanks
and sourced from official company press releases and documents.